Details for New Drug Application (NDA): 205085
✉ Email this page to a colleague
The generic ingredient in CARISOPRODOL is aspirin; carisoprodol; codeine phosphate. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; carisoprodol; codeine phosphate profile page.
Summary for 205085
Tradename: | CARISOPRODOL |
Applicant: | Orient Pharma Co Ltd |
Ingredient: | carisoprodol |
Patents: | 0 |
Pharmacology for NDA: 205085
Physiological Effect | Centrally-mediated Muscle Relaxation |
Medical Subject Heading (MeSH) Categories for 205085
Suppliers and Packaging for NDA: 205085
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CARISOPRODOL | carisoprodol | TABLET;ORAL | 205085 | ANDA | Proficient Rx LP | 63187-786 | 63187-786-20 | 20 TABLET in 1 BOTTLE (63187-786-20) |
CARISOPRODOL | carisoprodol | TABLET;ORAL | 205085 | ANDA | Proficient Rx LP | 63187-786 | 63187-786-30 | 30 TABLET in 1 BOTTLE (63187-786-30) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 350MG | ||||
Approval Date: | Oct 28, 2014 | TE: | AA | RLD: | No |
Complete Access Available with Subscription